Darunavir is a medication used to treat HIV. It works by stopping the virus from copying itself in the body. It's often taken with other medicines to help prevent the virus from becoming resistant.
Every report comes from a Lived member, sent anonymously.
Have you tried Prezista (Darunavir) for HIV Positive?
Darunavir, sold as Prezista and as generic tablets, is a prescription medicine for HIV-1, the type of HIV behind most infections. It belongs to a class of HIV medicines called protease inhibitors. It is approved for adults and for children 3 years and older, and it is always one part of a combination: it is taken with a booster medicine and with other HIV medicines, never on its own. Darunavir also comes in two combination tablets. Prezcobix pairs darunavir with cobicistat, a booster, and is still taken with other HIV medicines. Symtuza adds cobicistat plus emtricitabine and tenofovir alafenamide, two medicines from another HIV drug class, so a single tablet is a complete regimen for adults and children who weigh at least 40 kg (about 88 pounds). Both combination tablets are meant for people whose virus shows no resistance to darunavir. Symtuza also requires no resistance to tenofovir and is used either to start treatment or to switch for people whose virus is already suppressed on a stable regimen. Most people starting HIV treatment today begin with a regimen built on an integrase inhibitor, a newer class that includes dolutegravir and bictegravir. Darunavir-based treatment is a well-established alternative, often used for people who cannot take integrase inhibitors, who need to switch because of side effects, or whose earlier treatment stopped working. Darunavir does not cure HIV, but keeping the virus suppressed protects the immune system, lowers the chance of AIDS and HIV-related illness, and reduces the risk of passing HIV to others.
HIV copies itself inside the body's immune cells. To finish each new copy, the virus uses an enzyme called protease to cut long chains of viral protein into the working pieces a new virus needs. Darunavir blocks that enzyme, so the new virus particles cannot mature properly. Over time this lowers the amount of virus in the blood, called the viral load, and gives the immune system room to recover. On its own, darunavir is cleared from the body too quickly to work. It is broken down by an enzyme system called CYP3A, found mainly in the liver and gut. A small dose of ritonavir, or cobicistat in the combination tablets, blocks CYP3A and keeps darunavir at effective levels. This boosting is why darunavir is never taken alone, and it is also the source of most of its drug interactions, because the booster slows the breakdown of many other medicines too. Darunavir is paired with other HIV medicines that attack the virus at different steps, because HIV can mutate to escape a single drug. Darunavir is considered to have a high barrier to resistance, meaning the virus has a harder time becoming resistant to it than to some other HIV medicines.
Darunavir is taken by mouth with food, once or twice a day. Prezista comes as tablets and as a liquid for people who cannot swallow tablets, and it must be taken together with ritonavir, which is a separate pill or liquid. Prezcobix and Symtuza are single tablets taken once a day with food, with the booster already inside. For people who find them hard to swallow, Prezcobix and Symtuza tablets can be split into two pieces, with the whole dose taken right away; ask a pharmacist before splitting, crushing or chewing any tablet. The schedule depends on treatment history. Many adults take darunavir once a day. People whose virus already shows some darunavir resistance, or whose resistance status is unknown after earlier HIV treatment, usually take Prezista with ritonavir twice a day, and a resistance test of the virus guides that choice. During pregnancy, Prezista with ritonavir is usually taken twice a day because pregnancy lowers drug levels. Children's doses are based on body weight. Taking every dose matters more with HIV medicines than with many others. Missed doses let the virus multiply again and can lead to resistance, which may limit future treatment options. If a dose is missed, the usual advice is to take it when remembered unless the next dose is nearly due, and never to take a double dose. Darunavir or its booster should not be stopped, and neither dose changed, without the prescriber.
Diarrhea, nausea, headache, stomach pain and vomiting are the most common side effects, and most are mild. A rash affects about 1 in 10 people, usually within the first four weeks. It is mostly mild and often fades while treatment continues, but any new rash should be mentioned to the care team. Blood tests may also show rises in cholesterol, triglycerides or blood sugar. A small number of people develop a severe skin reaction. Stop darunavir and get medical care right away for a rash with fever, blistering or peeling skin, sores in the mouth, or red, swollen or watery eyes alongside a rash. Darunavir can occasionally inflame the liver, and serious liver injury, including rare deaths, has been reported, mostly in people with advanced HIV, hepatitis B or C, or many other medicines. Contact the care team promptly about yellowing of the skin or eyes, dark urine, pale stools, pain under the right ribs, or unusual tiredness with loss of appetite and nausea. Protease inhibitors can raise blood sugar, occasionally enough to bring on diabetes or worsen existing diabetes. Extreme thirst, frequent urination and blurred vision are worth reporting promptly. Changes in body fat, such as more fat around the belly or upper back and less in the face, arms or legs, have been seen with HIV treatment, though whether darunavir causes them is not established.
Because the booster slows the breakdown of many medicines, boosted darunavir interacts with a long list of drugs, and some combinations are dangerous. A few must never be combined with it, including simvastatin and lovastatin (cholesterol medicines that can build up and damage muscle), rifampin (a tuberculosis antibiotic that makes darunavir stop working), the herbal supplement St. John's wort, and certain heart rhythm, migraine, sedative and antipsychotic medicines. Others need a lower dose or closer monitoring, including atorvastatin and other cholesterol medicines, erectile dysfunction drugs such as sildenafil, some opioid pain medicines, and blood thinners such as apixaban. Steroids such as fluticasone or budesonide, even when inhaled, injected or used as a nasal spray, can build up enough to cause Cushing's syndrome (excess steroid effects such as weight gain, a rounded face and high blood pressure) and suppress the body's own steroid production. Before starting any new prescription, over-the-counter product or supplement, check with a pharmacist or the HIV care team. Ritonavir-boosted darunavir lowers the levels of birth control pills, so a non-hormonal method or an added barrier method such as condoms is recommended. Prezcobix and Symtuza have different guidance that depends on the type of hormonal contraceptive, so anyone using hormonal birth control with any darunavir product should confirm the method with the prescriber or pharmacist. During pregnancy, Prezista taken with ritonavir is the recommended form. Prezcobix and Symtuza are not recommended in pregnancy because darunavir and cobicistat levels fall too low in the second and third trimesters, so anyone who becomes pregnant should tell the care team promptly so the regimen can be reviewed. The label advises against breastfeeding while taking darunavir, and feeding plans are worth discussing with the HIV care team. Darunavir contains a sulfonamide (sulfa) component, so people with a sulfa drug allergy should mention it, although in studies rash was no more common in people with that allergy. People with hemophilia may bleed more easily on protease inhibitors. For people who also have hepatitis B, stopping Symtuza can cause a severe flare of hepatitis B, so it should only be stopped with a plan for follow-up liver tests. Darunavir is not used in children younger than 3 or in people with severe liver impairment.
Most people do not feel darunavir working. Progress is measured with blood tests: the viral load, which shows how much HIV is in the blood, and the CD4 count, which reflects how strong the immune system is. The aim is to suppress the virus, generally to fewer than 50 copies per milliliter of blood, a level usually reported as undetectable. Liver tests are checked before starting and during treatment, more closely in the first months for people with hepatitis or other liver problems, and blood sugar and cholesterol are monitored too. Symtuza also calls for a hepatitis B test before starting and regular kidney tests. Early stomach upset or a mild rash often settles within the first weeks. People who start treatment with a badly weakened immune system sometimes notice new or flaring symptoms of an old infection as their immunity recovers, and any new signs of infection should be reported promptly. HIV treatment is lifelong. Darunavir keeps working as long as doses are taken regularly and the virus has not become resistant, and stopping because one feels well allows the virus to rebound. Regimens can change over time for side effects, interactions, pregnancy plans or convenience, but changes are planned with the care team rather than made by skipping or stopping medicine.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Prezista (Darunavir), what you've noticed, or ask the community a question.